Japan Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: June 23, 2025 Report Code: GDME0628MDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “Japan Drug Delivery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Japan Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Infusion Systems, Central Venous Catheters and Implantable Ports

The Japan Drug Delivery Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Drug Delivery Devices Market.
• Global corporate-level profiles of key companies operating within the Japan Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Japan Drug Delivery Devices is segmented as follows –

• Infusion Systems

• Central Venous Catheters

• Implantable Ports

Reasons to Buy

The Japan Drug Delivery Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

B. Braun Melsungen AG_x000D_
Becton Dickinson and Co_x000D_
Teleflex Inc_x000D_
Baxter International Inc_x000D_
ICU Medical Inc_x000D_
Edwards Lifesciences Corp_x000D_
Vygon SA

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, Japan 10

3.1 Drug Delivery Devices Market, Japan, Revenue ($m), 2018-2033 10

3.2 Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2023 11

3.3 Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2023 12

3.4 Drug Delivery Devices Market, Japan, Revenue ($m), 2018-2033 13

3.5 Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 15

3.6 Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 16

3.7 Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), 2023 18

4 Central Venous Catheters Market, Japan 20

4.1 Central Venous Catheters Market, Japan, Revenue Mix ($m), 2023 20

4.2 Central Venous Catheters Market, Japan, Segment Contribution (%), 2023 21

4.3 Central Venous Catheters Market, Japan, Revenue ($m), 2018-2033 22

4.4 Central Venous Catheters Market, Japan, Volume (Units), 2018-2033 24

4.5 Central Venous Catheters Market, Japan, Average Price ($) , 2018-2033 26

4.6 Central Venous Catheters Market, Japan, Distribution Share by Revenue ($m), 2023 27

4.7 Central Venous Catheters Market, Japan, Company Share by Revenue ($m), 2023 28

5 Implantable Ports Market, Japan 30

5.1 Implantable Ports Market, Japan, Revenue Mix ($m), 2023 30

5.2 Implantable Ports Market, Japan, Segment Contribution (%), 2023 31

5.3 Implantable Ports Market, Japan, Revenue ($m), 2018-2033 32

5.4 Implantable Ports Market, Japan, Volume (Units), 2018-2033 34

5.5 Implantable Ports Market, Japan, Average Price ($) , 2018-2033 36

5.6 Implantable Ports Market, Japan, Distribution Share by Revenue ($m), 2023 37

5.7 Implantable Ports Market, Japan, Company Share by Revenue ($m), 2023 38

6 Infusion Systems Market, Japan 39

6.1 Infusion Systems Market, Japan, Revenue Mix ($m), 2023 39

6.2 Infusion Systems Market, Japan, Segment Contribution (%), 2023 40

6.3 Infusion Systems Market, Japan, Revenue ($m), 2018-2033 41

6.3.1 Infusion Pump Disposables Market, Japan, Revenue ($m), by Segment, 2018-2033 43

6.3.2 Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2018-2033 45

6.4 Infusion Systems Market, Japan, Volume (Units), 2018-2033 47

6.4.1 Infusion Pump Disposables Market, Japan, Volume (Units), by Segment, 2018-2033 49

6.4.2 Infusion Pumps Market, Japan, Volume (Units), by Segment, 2018-2033 51

6.5 Infusion Systems Market, Japan, Average Price ($) , 2018-2033 53

6.6 Infusion Systems Market, Japan, Distribution Share by Revenue ($m), 2023 54

6.7 Infusion Systems Market, Japan, Company Share by Revenue ($m), 2023 55

7 Overview of Key Companies in Japan, Drug Delivery Devices Market 56

7.1 B. Braun Melsungen AG 56

7.1.1 Company Overview 56

7.2 Becton Dickinson and Co 56

7.2.1 Company Overview 56

7.3 Teleflex Inc 56

7.3.1 Company Overview 56

7.4 AngioDynamics Inc 56

7.4.1 Company Overview 56

7.5 Edwards Lifesciences Corp 57

7.5.1 Company Overview 57

7.6 Vygon SA 57

7.6.1 Company Overview 57

7.7 Baxter International Inc 57

7.7.1 Company Overview 57

7.8 ICU Medical Inc 57

7.8.1 Company Overview 57

8 Drug Delivery Devices Market Pipeline Products 58

9 Financial Deals Landscape 66

9.1 Debt Offerings 66

9.1.1 Takeda Pharma Raises USD800 Million in Public Offering of

5.65% Senior Notes Due 2044 66

9.1.2 Takeda Pharma Raises USD500 Million in Public Offering of

5.800% Senior Notes Due 2064 68

9.1.3 Takeda Pharma Raises USD600 Million in Public Offering of

5.650% Senior Notes Due 2054 70

9.1.4 Takeda Pharma Raises USD1.1 Billion in Public Offering of

5.300% Senior Notes Due 2034 72

9.2 Equity Offerings 74

9.2.1 Terumo Raises USD1.26 Billion in Private Placement of Shares 74

9.2.2 Takeda Pharma Withdraws to Raise Upto USD1.4 Billion in Public Offering of Shares 77

9.3 Private Equity 78

9.3.1 New Horizon No 4 Investment Invests in Jokoh 78

10 Recent Developments 79

10.1 Corporate Communications 79

10.1.1 Apr 10, 2025: Hisamitsu Pharma Announces Executive Additions 79

10.2 Financial Announcements 79

10.2.1 Nov 13, 2024: Solasia Pharma K.K Announces Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2024 79

10.2.2 Aug 14, 2024: Solasia Pharma Reports Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2024 79

10.2.3 Aug 14, 2024: Solasia Pharma Announces Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2024 79

10.2.4 Aug 06, 2024: Cellectis Provides Financial Results for the Second Quarter 2024 79

10.2.5 Apr 26, 2024: Nitto Denko Announces Consolidated Financial Statements for the Year Ended March 31, 2024 81

10.3 Government and Public Interest 81

10.3.1 Sep 03, 2024: Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference 81

10.4 Other Significant Developments 82

10.4.1 Mar 03, 2025: Iconovo Receives a Grant of SEK 670,000 From Innowwide to Target the Japanese Market 82

11 Appendix 83

11.1 Research Methodology 84

11.1.1 Coverage 84

11.1.2 Secondary Research 84

11.1.3 Primary Research 85

11.1.4 Market Modeling and Forecasting 86

11.1.5 Company Share Analysis 87

11.1.6 Distribution Share Analysis 87

11.1.7 Benchmarking 88

11.2 GlobalData Consulting 88

11.3 Contact Us 88

11.4 Disclaimer 89

Table

Table 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2023 12

Table 3: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033 14

Table 4: Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 15

Table 5: Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 17

Table 6: Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 19

Table 7: Central Venous Catheters Market, Japan, Segment Contribution (%), 2023 21

Table 8: Central Venous Catheters Market, Japan, Revenue ($m), USD Constant, 2018-2033 23

Table 9: Central Venous Catheters Market, Japan, Volume (Units), 2018-2033 25

Table 10: Central Venous Catheters Market, Japan, Average Price ($), 2018-2033 26

Table 11: Central Venous Catheters Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 27

Table 12: Central Venous Catheters Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 29

Table 13: Implantable Ports Market, Japan, Segment Contribution (%), 2023 31

Table 14: Implantable Ports Market, Japan, Revenue ($m), USD Constant, 2018-2033 33

Table 15: Implantable Ports Market, Japan, Volume (Units), 2018-2033 35

Table 16: Implantable Ports Market, Japan, Average Price ($), 2018-2033 36

Table 17: Implantable Ports Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 37

Table 18: Implantable Ports Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 38

Table 19: Infusion Systems Market, Japan, Segment Contribution (%), 2023 40

Table 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, 2018-2033 42

Table 21: Infusion Pump Disposables Market, Japan, Revenue ($m), USD Constant, 2018-2033 44

Table 22: Infusion Pumps Market, Japan, Revenue ($m), USD Constant, 2018-2033 46

Table 23: Infusion Systems Market, Japan, Volume (Units), 2018-2033 48

Table 24: Infusion Pump Disposables Market, Japan, Volume (Units), 2018-2033 50

Table 25: Infusion Pumps Market, Japan, Volume (Units), 2018-2033 52

Table 26: Infusion Systems Market, Japan, Average Price ($), 2018-2033 53

Table 27: Infusion Systems Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 54

Table 28: Infusion Systems Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 55

Table 29: Drug Delivery Devices Market Pipeline Products 58

Table 30: Takeda Pharma Raises USD800 Million in Public Offering of 5.65% Senior Notes Due 2044 66

Table 31: Takeda Pharma Raises USD500 Million in Public Offering of 5.800% Senior Notes Due 2064 68

Table 32: Takeda Pharma Raises USD600 Million in Public Offering of 5.650% Senior Notes Due 2054 70

Table 33: Takeda Pharma Raises USD1.1 Billion in Public Offering of 5.300% Senior Notes Due 2034 72

Table 34: Terumo Raises USD1.26 Billion in Private Placement of Shares 74

Table 35: Takeda Pharma Withdraws to Raise Upto USD1.4 Billion in Public Offering of Shares 77

Table 36: New Horizon No 4 Investment Invests in Jokoh 78

Table 37: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country 85

Figures

Figure 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2023 11

Figure 3: Drug Delivery Devices Market, Japan, Category Contribution (%), 2023 12

Figure 4: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033 13

Figure 5: Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 15

Figure 6: Drug Delivery Devices Market, Japan, Volume (Units), 2018-2033 16

Figure 7: Drug Delivery Devices Market, Japan, Company Share (%) 2023 18

Figure 8: Central Venous Catheters Market, Japan, Revenue Mix ($m), 2023 20

Figure 9: Central Venous Catheters Market, Japan, Segment Contribution (%), 2023 21

Figure 10: Central Venous Catheters Market, Japan, Revenue ($m), USD Constant, 2018-2033 22

Figure 11: Central Venous Catheters Market, Japan, Volume (Units), 2018-2033 24

Figure 12: Central Venous Catheters Market, Japan, Company Share (%) 2023 28

Figure 13: Implantable Ports Market, Japan, Revenue Mix ($m), 2023 30

Figure 14: Implantable Ports Market, Japan, Segment Contribution (%), 2023 31

Figure 15: Implantable Ports Market, Japan, Revenue ($m), USD Constant, 2018-2033 32

Figure 16: Implantable Ports Market, Japan, Volume (Units), 2018-2033 34

Figure 17: Implantable Ports Market, Japan, Company Share (%) 2023 38

Figure 18: Infusion Systems Market, Japan, Revenue Mix ($m), 2023 39

Figure 19: Infusion Systems Market, Japan, Segment Contribution (%), 2023 40

Figure 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, 2018-2033 41

Figure 21: Infusion Pump Disposables Market, Japan, Revenue ($m), USD Constant, 2018-2033 43

Figure 22: Infusion Pumps Market, Japan, Revenue ($m), USD Constant, 2018-2033 45

Figure 23: Infusion Systems Market, Japan, Volume (Units), 2018-2033 47

Figure 24: Infusion Pump Disposables Market, Japan, Volume (Units), 2018-2033 49

Figure 25: Infusion Pumps Market, Japan, Volume (Units), 2018-2033 51

Figure 26: Infusion Systems Market, Japan, Company Share (%) 2023 55

Japan Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Japan Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems in real time.

Access a live Japan Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Japan Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports